Financial Highlights - Summary of Financial Highlights (Detail) - USD ($) $ / shares in Units, $ in Thousands		3 Months Ended				12 Months Ended
		Mar. 31, 2025		Mar. 31, 2024		Dec. 31, 2024
Per Share Data:
Net asset value per share of Common Stock, beginning of period	[1],[2]	$ 24.82
Net investment income (loss)	[3],[5]	(0.02)	[2],[4]	$ 0
Net realized and unrealized gain (loss)	[2],[4]	(0.02)
Total increase (decrease) in net assets resulting from investment operations	[2]	(0.04)
Distributions of net investment income to preferred shareholders	[2]	0
Total distributions to preferred shareholders	[2]	0
Net increase (decrease) in net assets relating to capital share transactions	[2],[6]	0
Total increase (decrease) in net assets applicable to holders of Common Stock from capital share transactions	[2]	0
Total increase (decrease) in net assets applicable to holders of Common Stock	[2]	(0.04)
Net asset value per share of Common Stock, end of period	[1],[2]	$ 24.78				$ 24.82
Total return based on net asset value	[2],[7]	(0.16%)
Ratios:
Ratio of net investment income (loss) to average net assets applicable to Common Stock	[2],[8],[9]	2.74%
Ratio of total expenses to average net assets applicable to Common Stock, gross	[2],[8],[9]	19.10%
Ratio of total expenses to average net assets applicable to Common Stock, net of waivers	[2],[8],[9]	5.75%
Portfolio turnover rate	[2],[10]	0.00%
Supplemental Data:
Net assets, end of period	[2]	$ 72,338
Shares of Common Stock outstanding, end of period		2,857,196	[2]	0		1,242,991
Weighted average shares of Common Stock outstanding, basic	[3]	1,350,604	[2]	0	[11]
Weighted average shares of Common Stock outstanding, diluted	[3]	1,350,604	[2]	0	[11]
Total capital commitments, end of period		$ 640,456	[2]			$ 604,804
Ratio of total contributed capital to total committed capital, end of period	[2]	11.07%
Asset coverage ratio	[2]	244.05%

[1] (2) Net asset value per share of Common Stock may not recalculate due to rounding.

[2] Financial highlights for the three months ended March 31, 2024 are not presented as this period was prior to August 30, 2024, the date on which the Company became subject to the reporting requirements under the 1934 Act.

[3] (2) There were no shares of Common Stock outstanding for the three months ended March 31, 2024.

[4] Per share amounts are calculated based on the weighted average shares outstanding during the period.

[5] (1) Net investment income (loss) per share of Common Stock (basic and diluted) and earnings per share of Common Stock (basic and diluted) may not recalculate due to rounding

[6] The amount shown at this caption is the balancing amount derived from the other figures in this schedule. The amount shown for capital share transactions, including share issuances, will fluctuate due to the timing of the share issuances and the weighted average shares over the period.

[7] Total return is calculated as the change in net asset value per share of Common Stock during the period, plus distributions per share of Common Stock, if any, divided by the net asset value per share of Common Stock at the beginning of the period. Total return is for the period indicated and has not been annualized.

[8] Amounts are annualized except for organizational and offering costs, expense support amounts relating to organizational and offering costs, and reimbursement of expense support. The ratio of total expenses to average net assets applicable to Common Stock, gross excludes the effect of expenses waived by the Advisor, expense support, and reimbursement of expense support which represented 13.35% of average net assets.

[9] The amounts reflected for the respective period do not reflect the effect of dividends earned but not declared or dividend payments to preferred shareholders.

[10] Portfolio turnover rate is calculated using the lesser of total sales or total purchases over the average of the investments at fair value for the period reported.

[11] There were no shares of Common Stock outstanding as of March 31, 2024, or for the three months ended March 31, 2024.